#USA #Clearwater #Florida Cancer Specialists #Troy Fishman #Yeshanew Teklie

Enhancing Cancer Care in Florida: New Additions to Florida Cancer Specialists

The Florida Cancer Specialists & Research Institute (FCS) is excited to announce the addition of two accomplished physicians to their growing team. Dr. Troy Fishman and Dr. Yeshanew Teklie have joined FCS, expanding the organization’s capacity to provide top-notch cancer treatment across the state.

Welcoming Dr. Fishman and Dr. Teklie

Dr. Fishman, who specializes in oncology, will be working at the FCS Mease clinic located in Clearwater, while Dr. Teklie, a hematology expert, will see patients at various locations, including the FCS Brownwood clinic in The Villages, the FCS Leesburg South clinic, and the FCS Villages Cancer Center in Lady Lake. Their recruitment not only signifies growth for FCS but also enhances access to specialized treatments for patients battling cancer in Pinellas County and surrounding areas.

Dr. Fishman received his medical degree from St. George's University School of Medicine in Grenada and completed his residency at the University of Central Florida, followed by a fellowship in oncology/hematology in Providence, Rhode Island. According to Dr. David Wenk, Assistant Managing Physician at FCS, Dr. Fishman puts great emphasis on understanding each patient’s needs and tailoring treatment plans to improve their quality of life.

Conversely, Dr. Teklie completed his medical degree at Ross University School of Medicine and further trained at Florida State University before completing a hematology oncology fellowship at USC LAC+USC Medical Center in Los Angeles. Recognized for his commitment to service and community care, Dr. Teklie brings valuable expertise in treating hematologic cancers and blood disorders, which are increasingly prevalent in older populations.

A Commitment to Advanced Cancer Care

FCS has been a pioneer in oncology care for over 40 years, renowned for embracing innovation and delivering world-class treatment through its dynamic clinical research program. Not only does FCS help patients navigate treatment options, but it also provides access to numerous clinical trials, ensuring they can benefit from the latest advancements in cancer therapies. In many instances, new cancer drugs receive FDA approval only after first being made available to patients through participation in trials at FCS.

FCS has consistently aimed to leverage cutting-edge technologies and precision oncology advancements to optimize patient outcomes. The addition of Dr. Fishman and Dr. Teklie further solidifies the organization’s commitment to delivering bespoke treatment plans tailored to individual patient needs.

For those looking to learn more about their new physicians or to schedule an appointment, information is available at FLSpecialists.com.

Conclusion

The commitment of Florida Cancer Specialists & Research Institute to its patients is evident through its strategic growth and the caliber of professionals it attracts. With the inclusion of Dr. Fishman and Dr. Teklie, FCS continues to enhance cancer care for patients throughout Florida, bringing hope and innovation to a field that profoundly impacts lives. The future looks bright for patients as they access some of the most advanced treatments currently available in oncology and hematology.